EDGe Surgical Names New CEO

There’s a new face in the corner office at EDGe Surgical. The company has appointed Leo Carayannopoulos as CEO.

Carayannopoulos brings a strong track record of medtech industry leadership, with extensive experience in commercial strategy, product development, and scaling high-growth healthcare ventures. His appointment follows EDGe Surgical’s recent financing round and coincides with the company’s focus on expanding its product portfolio and commercializing its solutions.

As CEO, Carayannopoulos will lead EDGe’s strategic direction and operational execution, with a focus on building out the company’s commercial infrastructure and driving adoption across surgical centers nationwide.

“We have a unique opportunity to make a real, measurable impact in orthopedic surgery,” Carayannopoulos stated. “The Ortho EDG reduces the cost of plate-and-screw procedures by cutting down on wasted implants, saving OR time, simplifying sterile processing workflows, and eliminating a point of secondary infection risk. With over 2,000 procedures completed to date, we aim to make Ortho EDG the standard of care for all trauma procedures.”

EDGe’s flagship product, the Ortho EDG, is a sterile, single-use digital depth gauge designed to improve intraoperative measurement accuracy, reduce implant waste, minimize OR time, and lower the risk of surgical site infections. The company is preparing to launch new 100mm and 35mm SKUs to enhance the platform’s procedural versatility.

EDGe Surgical is a Chicago-based medical device company developing and commercializing single-use digital instruments for orthopedic and spine procedures. Its flagship product delivers real-time digital measurement to improve surgical accuracy and reduce the risks associated with traditional reusable tools.